These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies. Boratyńska M, Watorek E, Smolska D, Patrzałek D, Klinger M. Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973 [Abstract] [Full Text] [Related]
7. Renal transplantation in patients with Balkan endemic nephropathy. Basic-Jukic N, Hrsak-Puljic I, Kes P, Bubic-Filipi L, Pasini J, Hudolin T, Kastelan Z, Reiner Z, Kordic M, Brunetta B, Juric I. Transplant Proc; 2007 Jun; 39(5):1432-5. PubMed ID: 17580155 [Abstract] [Full Text] [Related]
8. Early de novo malignancies after kidney transplantation. Veroux M, Puliatti C, Fiamingo P, Cappello D, Macarone M, Puliatti D, Vizcarra D, Gagliano M, Veroux P. Transplant Proc; 2004 Apr; 36(3):718-20. PubMed ID: 15110643 [Abstract] [Full Text] [Related]
11. Long-term kinetics of a T-lymphocytes subset in kidney transplant recipients: relationship with posttransplant malignancies. Glowacki F, Al Morabiti M, Lionet A, Labalette M, Provot F, Noel C, Hazzan M. Transplant Proc; 2009 Oct; 41(8):3323-5. PubMed ID: 19857742 [Abstract] [Full Text] [Related]
12. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients]. di Capua Sacoto C, Luján Marco S, Bahilo Mateu P, Budía Alba A, Pontones Moreno JL, Jiménez Cruz JF. Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138 [Abstract] [Full Text] [Related]
13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL. Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [Abstract] [Full Text] [Related]
16. Development of malignancy following living donor kidney transplantation. Nafar M, Einollahi B, Hemati K, Gholi FP, Firouzan A. Transplant Proc; 2005 Sep; 37(7):3065-7. PubMed ID: 16213306 [Abstract] [Full Text] [Related]
17. [Incidence of de novo neoplasms after liver transplantation]. Berenguer M, Prieto M, Bustamante M, Carrasco D, López-Andújar R, Mir J, Berenguer J. Med Clin (Barc); 1998 Oct 24; 111(13):481-4. PubMed ID: 9859063 [Abstract] [Full Text] [Related]
19. Development of lymphoproliferative disease after liver transplantation. Marqués E, Jiménez C, Manrique A, Vallejo GH, Clemares M, Ortega P, Moreno E. Transplant Proc; 2008 Nov 24; 40(9):2988-9. PubMed ID: 19010169 [Abstract] [Full Text] [Related]
20. Incidence of cancer after kidney transplant: results from the North Italy transplant program. Pedotti P, Cardillo M, Rossini G, Arcuri V, Boschiero L, Caldara R, Cannella G, Dissegna D, Gotti E, Marchini F, Maresca MC, Montagnino G, Montanaro D, Rigotti P, Sandrini S, Taioli E, Scalamogna M. Transplantation; 2003 Nov 27; 76(10):1448-51. PubMed ID: 14657684 [Abstract] [Full Text] [Related] Page: [Next] [New Search]